Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I-II Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell Injection in Patients With Decompensated Hepatitis B Cirrhosis

NCT07413549 is registered in ClinicalTrials.gov with Beijing Tuohua Weiye Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07413549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I-II Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell Injection in Patients With Decompensated Hepatitis B Cirrhosis
Lead sponsor
Beijing Tuohua Weiye Biotechnology Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 25, 2025
Completion date
December 31, 2027
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated hepatitis b cirrhosis